CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for J Communications Co., Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

J Communications Co., Ltd.
123-4 Ojeon-Dong
Phone: +82 314287200p:+82 314287200 Euiwang City, Gyunggi-Do, 437-819  South Korea Fax: +82 314512994f:+82 314512994
Business Summary
J Communications Co., Ltd. is a Korea-based company engaged in the pharmaceutical and wireless communication device businesses. Its pharmaceutical business is involved in the importation and original equipment manufacturing (OEM) of active pharmaceutical ingredients (APIs), including taurine, artemisa extract, d-serine, citric acid anhydrous, simvastatin, caffeine, acetaminophen, 2-aemp, clopidogrel and maltitol. Its wireless communication device business provides global positioning system (GPS) modules, GPS antennas, car black boxes, car navigation devices, camera detectors, wireless telegraphy devices and other related products. It also operates bio business, which is engaged in the research and development of protein pharmaceuticals, antibiotic pharmaceutical and stem cell remedies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/200912/31/2009Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
3669 Communications equipment, not elsewhere classified
3663 Radio and television broadcasting and communications equipment

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Gwang SeonHan 34 8/9/2010 8/9/2010
Co-Chief Executive Officer, Director Yong SeokKang 42 10/6/2008 2/1/2008
Internal Auditor Jong GeunYoon 51 8/9/2010 8/9/2010
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 49 (As of 12/31/2009)
Outstanding Shares: 42,813,650 (As of 12/31/2009)
Shareholders: 8,291
Stock Exchange: KDQ
Fax Number: +82 314512994


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023